128 related articles for article (PubMed ID: 15153869)
1. A comparison of the hormone levels in patients with Sjogren's syndrome and healthy controls.
Taiym S; Haghighat N; Al-Hashimi I
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):579-83. PubMed ID: 15153869
[TBL] [Abstract][Full Text] [Related]
2. IgA rheumatoid factor in primary Sjogren's syndrome.
Peen E; Mellbye OJ; Haga HJ
Scand J Rheumatol; 2009; 38(1):46-9. PubMed ID: 18942022
[TBL] [Abstract][Full Text] [Related]
3. Comparison of salivary calmodulin binding proteins in Sjögren's syndrome and healthy individuals.
Deming FP; Al-Hashimi I; Haghighat N; Hallmon WW; Kerns DG; Abraham C; Rivera-Hidalgo F
J Oral Pathol Med; 2007 Mar; 36(3):132-5. PubMed ID: 17305633
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of serum metabolic alterations in primary Sjögren's syndrome: influence on clinical and immunological expression.
Ramos-Casals M; Brito-Zerón P; Sisó A; Vargas A; Ros E; Bove A; Belenguer R; Plaza J; Benavent J; Font J
J Rheumatol; 2007 Apr; 34(4):754-61. PubMed ID: 17309127
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of soluble CD44 in primary Sjögren's syndrome.
Levesque MC; Mackin DA; Fleming JA; St Clair EW
J Rheumatol; 2000 Jun; 27(6):1444-9. PubMed ID: 10852268
[TBL] [Abstract][Full Text] [Related]
6. Salivary anti-spectrin autoantibodies in Sjögren's syndrome.
Moody M; Zipp M; Al-Hashimi I
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):322-7. PubMed ID: 11250630
[TBL] [Abstract][Full Text] [Related]
7. Endogenous hormones in postmenopausal females with breast cancer--before and after treatment.
Trehan AS; Arora MK; Seth S; Chauhan A
Clin Lab; 2012; 58(7-8):771-7. PubMed ID: 22997978
[TBL] [Abstract][Full Text] [Related]
8. Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren's syndrome.
Hammi AR; Al-Hashimi IH; Nunn ME; Zipp M
J Oral Pathol Med; 2005 Apr; 34(4):198-203. PubMed ID: 15752253
[TBL] [Abstract][Full Text] [Related]
9. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
10. [Association between endogenous hormones, hormone receptors and cervical cancer].
Wang JT; Gao ES; Ding L; Cheng YY; Yan JW
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):494-7. PubMed ID: 17147111
[TBL] [Abstract][Full Text] [Related]
11. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Rosner B; Sluss P; Hankinson SE
Cancer Res; 2004 Sep; 64(18):6814-9. PubMed ID: 15375001
[TBL] [Abstract][Full Text] [Related]
12. Sex hormone ratio changes in men and postmenopausal women with coronary artery disease.
He H; Yang F; Liu X; Zeng X; Hu Q; Zhu Q; Tu B
Menopause; 2007; 14(3 Pt 1):385-90. PubMed ID: 17108845
[TBL] [Abstract][Full Text] [Related]
13. The significance of salivary and serum interleukin 6 and basic fibroblast growth factor levels in patients with Sjögren's syndrome.
Boras VV; Cikes N; Lukac J; Cekić-Arambasin A; Virag M; Bosnjak A
Coll Antropol; 2004; 28 Suppl 2():305-9. PubMed ID: 15571105
[TBL] [Abstract][Full Text] [Related]
14. The effect of parotid salivary flow rate on the levels of salivary antimicrobial proteins in patients with Sjögren's syndrome.
Zipp MM; Yasbin L; al-Hashimi I
Quintessence Int; 1999 Oct; 30(10):700-5. PubMed ID: 10765854
[TBL] [Abstract][Full Text] [Related]
15. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].
Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966
[TBL] [Abstract][Full Text] [Related]
16. Periodontal status and sulcular Candida albicans colonization in patients with primary Sjögren's Syndrome.
Rhodus NL; Michalowicz BS
Quintessence Int; 2005 Mar; 36(3):228-33. PubMed ID: 15887508
[TBL] [Abstract][Full Text] [Related]
17. Sjögren's syndrome sufferers have increased oral yeast levels despite regular dental care.
Leung KC; McMillan AS; Cheung BP; Leung WK
Oral Dis; 2008 Mar; 14(2):163-73. PubMed ID: 18302677
[TBL] [Abstract][Full Text] [Related]
18. Sjögren's syndrome induced by estrogen therapy.
Nagler RM; Pollack S
Semin Arthritis Rheum; 2000 Dec; 30(3):209-14. PubMed ID: 11124284
[TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
[TBL] [Abstract][Full Text] [Related]
20. IL-10 promoter -1082 polymorphism is associated with elevated IL-10 levels in control subjects but does not explain elevated plasma IL-10 observed in Sjögren's syndrome in a Hungarian cohort.
Márka M; Bessenyei B; Zeher M; Semsei I
Scand J Immunol; 2005 Nov; 62(5):474-80. PubMed ID: 16305644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
